Astrazeneca Pharma India Ltd:
* Received import and market permission in form 45 from DCGI (Drug Controller General of India)for FDC of Budesonide 320 μg + Formoterol Fumarate Dihydrate 9 μg inhalation powder
* Says drug indicated for treatment of asthma Source text for Eikon: Further company coverage:
